ArticleMedicine2025

Post-marketing safety assessment of Tyrvaya: A real-world pharmacovigilance analysis based on the FDA Adverse Event Reporting System.

Chang-Zhu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.